JLens 500 Jewish Advocacy U.S. ETF (NYSEARCA:TOV – Get Free Report) was the target of a large decrease in short interest in the month of January. As of January 30th, there was short interest totaling 7,560 shares, a decrease of 50.7% from the January 15th total of 15,332 shares. Currently, 0.1% of the company’s shares are sold short. Based on an average daily volume of 5,414 shares, the days-to-cover ratio is presently 1.4 days. Based on an average daily volume of 5,414 shares, the days-to-cover ratio is presently 1.4 days. Currently, 0.1% of the company’s shares are sold short.
JLens 500 Jewish Advocacy U.S. ETF Trading Down 1.3%
TOV traded down $0.39 on Thursday, hitting $28.69. The company had a trading volume of 3,243 shares, compared to its average volume of 6,408. The firm has a market cap of $206.57 million, a P/E ratio of 25.69 and a beta of 1.00. The company’s fifty day moving average price is $28.94 and its 200 day moving average price is $28.20. JLens 500 Jewish Advocacy U.S. ETF has a 1 year low of $20.40 and a 1 year high of $29.92.
Hedge Funds Weigh In On JLens 500 Jewish Advocacy U.S. ETF
An institutional investor recently bought a new position in JLens 500 Jewish Advocacy U.S. ETF stock. Captrust Financial Advisors bought a new stake in JLens 500 Jewish Advocacy U.S. ETF (NYSEARCA:TOV – Free Report) in the 2nd quarter, according to its most recent disclosure with the SEC. The fund bought 231,726 shares of the company’s stock, valued at approximately $6,038,000. Captrust Financial Advisors owned approximately 3.60% of JLens 500 Jewish Advocacy U.S. ETF at the end of the most recent reporting period.
About JLens 500 Jewish Advocacy U.S. ETF
The JLens 500 Jewish Advocacy U.S. ETF (TOV) is an exchange-traded fund that is based on the JLens 500 Jewish Advocacy U.S. index. The fund tracks an index of large-cap US stocks while employing a methodology that seeks to align stock selection and weighting with Jewish value pillars. TOV was launched on Feb 26, 2025 and is issued by JLens.
Recommended Stories
- Five stocks we like better than JLens 500 Jewish Advocacy U.S. ETF
- USAU: The U.S. Gold-Copper Story Investors Can’t Ignore.
- The DoD just got a new drone supplier
- Think You Missed Silver? You’re Wrong. Here’s Why.
- When to buy gold (mathematically)
- ISPC: From Small Cap to Life Sciences Market Disruptor!
Receive News & Ratings for JLens 500 Jewish Advocacy U.S. ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for JLens 500 Jewish Advocacy U.S. ETF and related companies with MarketBeat.com's FREE daily email newsletter.
